Shankman Michael Elliot
SEC insider (Form 3/4/5 filer). CIK 0002035175. Chief Financial Officer at Lexaria Bioscience Corp. (LEXX). 1 reported Form 4/5 transaction since Sep 2024; latest on May 15, 2025. Located in DANVILLE, CA.
Companies Shankman Michael Elliot has filed insider reports for
- Lexaria Bioscience Corp. (LEXX): Officer, Chief Financial Officer
Shankman Michael Elliot
CIK: 0002035175
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXX
Lexaria Bioscience Corp.
Officer